Moderna Inc
FDA decision on Novavax’s Covid shots could be delayed to review changes in manufacturing
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images The Food and Drug Administration needs to review changes to Novavax’s manufacturing process before it can authorize the biotech […]
Read More
Stocks making the biggest moves midday: DocuSign, Campbell, Moderna and more
The Docusign Inc. website on a laptop computer arranged in Dobbs Ferry, New York, U.S., on Thursday, April 1, 2021. Tiffany Hagler-Geard | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Campbell Soup – The food company saw shares gain 2.3% after reporting a better-than-expected quarterly report. Campbell posted an […]
Read More
5 things to know before the stock market opens Wednesday
Here are the most important news, trends and analysis that investors need to start their trading day: 1. Stock futures fall with the 10-year Treasury yield above 3% Trader on the floor of the NYSE, June 7, 2022. Source: NYSE U.S. stock futures fell Wednesday after back-to-back gains on Wall Street. Adding pressure, the benchmark […]
Read More
Stocks making the biggest moves premarket: Campbell Soup, Moderna, Western Digital and others
Check out the companies making headlines before the bell: Campbell Soup (CPB) – The food producer’s shares rallied 3.7% in the premarket after Campbell reported an adjusted quarterly profit of 70 cents per share, 9 cents above estimates. Sales also beat forecasts, and the company raised its full-year sales outlook. Campbell also maintained its prior […]
Read More
Ford tops the list of the cheapest stocks in the market right now
While the short-term market outlook looks quite precarious, investors seeking buys for the long term are likely finding tons of value possibilities after the sizable pullback in stocks so far this year. CNBC PRO ran a screen looking for the cheapest stocks relative to the rest of the market and their historical valuations. Here’s the […]
Read More
Novavax faces high stakes FDA review this week that will decide the fate of its Covid vaccine in the U.S.
In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials. Pavlo Gonchar | LightRocket | Getty Images Novavax’s Covid-19 vaccine will face the scrutiny of the Food and Drug Administration’s independent immunization experts this week, a crucial step on the path toward U.S. regulatory […]
Read More
White House expects Covid vaccinations for children under age 5 to begin as early as June 21
A nurse administers a pediatric dose of the Covid-19 vaccine to a girl at a L.A. Care Health Plan vaccination clinic at Los Angeles Mission College in the Sylmar neighborhood in Los Angeles, California, January 19, 2022. Robyn Beck | AFP | Getty Images Covid vaccinations for children under age 5 are expected to begin […]
Read More
FDA panel sets June 15 meeting on Pfizer, Moderna Covid vaccines for infants and toddlers
Bridgette Melo, 5, prepares for her inoculation of one of two reduced 10 ug doses of the Pfizer BioNtech COVID-19 vaccine during a trial at Duke University in Durham, North Carolina September 28, 2021 in a still image from video. Shawn Rocco | Duke University | via Reuters The Food and Drug Administration’s expert committee […]
Read More
Pfizer says third Covid vaccine shot for kids under 5 is 80% effective against omicron
A healthcare worker administers a Pfizer-BioNTech Covid-19 vaccine to a child at vaccination site in San Francisco, California, U.S., on Monday, Jan. 10, 2022. David Paul Morris | Bloomberg | Getty Images Pfizer and BioNTech’s three-dose Covid vaccine for children six months to 5-years-old was 80% effective at preventing illness during the omicron wave, according […]
Read More
Novavax confident Covid vaccine will receive FDA authorization in June after delays
Novavax is confident its Covid-19 vaccine will receive the endorsement of the Food and Drug Administration’s advisory committee early this summer, executives said this week. The FDA committee is scheduled to meet on June 7 to review Novavax’s submission. An endorsement from the committee, which is made up of independent experts, would mean the drug […]
Read More